Neurotechnology/Integrated system
Implanted visual prostheses
Implanted devices that replace or bypass the eye's light-sensing cells, aiming at sight equal to or better than natural vision, with added readouts and night vision.
State of the art
Science Corporation's PRIMA subretinal photovoltaic implant let most patients with geographic atrophy read letters and words again at 12 months in a pivotal trial (NEJM, 2026).
What’s blocking it
- Pixel density and field of view far below the natural retina
- Implants only work while some retinal or cortical circuitry survives
- Encoding color and natural percepts rather than flashes of light
Who’s working on it
- Science Corporation ↗Startup
Acquired and took the PRIMA subretinal implant through its pivotal trial and regulatory filing
- Daniel PalankerResearcherStanford University
Invented the photovoltaic subretinal implant technology behind PRIMA
What to invest in
| Kind | Investment | Scale |
|---|---|---|
| research | Higher-density photovoltaic and optogenetic retinal interfaces | $$ $10M – $100M |
| engineering | Cortical visual prostheses for people with no surviving retina | $$$ $100M – $1B |
Depends on
High-density chronic neural interfaces
Thousands of stimulation sites to form a detailed image
TRL 6
High-fidelity sensory writing into cortex
Producing natural-looking percepts rather than phosphenes
TRL 5
Required by
No other capability builds on this directly.